Date	Safety Update
14-Mar-2019	Press Statement: Fluoroquinole Antibiotics, Hydrochlorthiazide Products and Valsartan Containing Products
14-Jan-2019	Hydrochlorothiazide (HCTZ) Risk of Non-Melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)
14-Jan-2019	Systemic and inhaled quinolone and fluoroquinolone antibiotics
12-Jul-2018	Recall of Valsartan containing products by Denk Pharma
11-Jul-2018	Recall of some specific brands of Gentamicin injection in the Kenyan market
11-Jul-2018	Recall of specific batches of Folfes tablets, Hexon 5% disinfectant and Ventil tablets from Biodeal Laboratories Ltd
9-May-2018	Alert on Falsified Postinor-2
8-May-2018	Important identified signals on Artemether Lumefantrine
8-May-2018	Important identified signals on Ceftriaxone
8-May-2018	Alert on falsified Primaquine
26-Mar-2018	Recall of Gentamed injection batch no. 170603
8-Aug-2013	Suspension of registration of Hydroethyl Starch (HES) containing solutions
19-Mar-2010	Increased risk of myopathy with high doses of Simvastatin
23-Feb-2010	Prolongation of the QT interval due to Saquinavir boosted with Ritonavir
29-Jan-2010	Risk of non-cirrhotic portal hypertension in patients using Didanosine
21-Jul-2009	Public Alert on Herbal Contraceptive
21-Apr-2009	Updated recommendations concerning the interaction of Ceftriaxone and Calcium containing products